🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This multicenter, open-label, Phase I study will evaluate the safety, effic...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2015-07-22
Trial ID
NCT02431208
The purpose of this study is to compare the efficacy of ciltacabtagene auto...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2020-06-12
Trial ID
NCT04181827
Treatments Being Tested
Primary Objectives: * To evaluate the safety and tolerability of isatuxima...
Status
Completed
Location
~Banner MD Anderson Cancer Center Site Number : 8400005
Start Date
2019-08-06
Trial ID
NCT04045795
This study is researching a drug called linvoseltamab (also called "study d...
Status
Recruiting
Location
Emory Winship Cancer Institute
Start Date
2026-01-02
Trial ID
NCT07222761
Treatments Being Tested
The purpose of this study is to evaluate the effects of the addition of dar...
Status
Completed
Location
Antwerpen
Start Date
2017-06-14
Trial ID
NCT03180736
Treatments Being Tested
Multiple myeloma (MM) is a plasma cell malignancy characterized by the prol...
Status
Not Yet Recruiting
Location
University of Arizona Cancer Center /ID# 285339
Start Date
2026-11-30
Trial ID
NCT07728188
Treatments Being Tested
This study is a Phase Ib, open label, single arm, adaptive multi-centre cli...
Status
Active Not Recruiting
Location
Cork University Hospital
Start Date
2021-12-08
Trial ID
NCT04667663
Treatments Being Tested
This is a phase 1/2, open label, single-center study designed to assess the...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2022-10-20
Trial ID
NCT05581875
Treatments Being Tested
This trial will study how safely the tazemetostat works with other therapie...
Status
Withdrawn
Location
California Cancer Associates For Research And Excellence, cCARE
Start Date
2021-12-22
Trial ID
NCT05205252
The purpose of this study is to assess the safety, tolerability, and effica...
Status
Recruiting
Location
University of Alabama At Birmingham Hospital
Start Date
2021-09-16
Trial ID
NCT04973605
Treatments Being Tested